“Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma” has been added to your cart. View cart
Article: P57 Characterization of regulatory T cell (Treg) subsets after allogeneic hematopoietic cell transplantation
P57 Characterization of regulatory T cell (Treg) subsets after allogeneic hematopoietic cell transplantation
Reviews
There are no reviews yet.
Be the first to review “Article: P57 Characterization of regulatory T cell (Treg) subsets after allogeneic hematopoietic cell transplantation” Cancel reply
Reviews
There are no reviews yet.